Catherine Gérard

7.9k total citations · 1 hit paper
109 papers, 6.4k citations indexed

About

Catherine Gérard is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Catherine Gérard has authored 109 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Immunology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Catherine Gérard's work include Immunotherapy and Immune Responses (18 papers), Thyroid Disorders and Treatments (10 papers) and Food composition and properties (9 papers). Catherine Gérard is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Thyroid Disorders and Treatments (10 papers) and Food composition and properties (9 papers). Catherine Gérard collaborates with scholars based in Belgium, United States and Canada. Catherine Gérard's co-authors include Thierry Velu, Anne Delvaux, Michel Goldman, Arnaud Marchant, Jason Perret, Marc Parmentier, Daniel Abramowicz, Anne Lefort, Charles J. Doillon and Jake E. Barralet and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Catherine Gérard

108 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

1993 679 citations Catherine Gérard, Catherine Bruyns et al. The Journal of Experimental Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Catherine Gérard	1.8k	1.5k	873	845	681	109	6.4k
Janet Lee	2.2k 1.2×	3.6k 2.5×	234 0.3×	261 0.3×	834 1.2×	259	10.9k
Richard A. Smith	1.6k 0.9×	3.3k 2.2×	240 0.3×	245 0.3×	688 1.0×	358	10.8k
David W. Barnes	1.1k 0.6×	3.1k 2.1×	210 0.2×	242 0.3×	1.1k 1.6×	193	7.5k
Jeffrey M. Davidson	848 0.5×	3.6k 2.4×	187 0.2×	615 0.7×	656 1.0×	191	13.2k
Brian Harmon	1.2k 0.7×	3.3k 2.2×	187 0.2×	183 0.2×	1.2k 1.8×	44	6.0k
Michael Cross	637 0.4×	3.9k 2.6×	153 0.2×	279 0.3×	856 1.3×	137	8.5k
Kenneth Olden	962 0.5×	4.4k 3.0×	242 0.3×	161 0.2×	955 1.4×	150	8.8k
Kevin Jon Williams	2.2k 1.2×	4.7k 3.2×	444 0.5×	1.7k 2.0×	472 0.7×	186	12.7k
Anna Villa	3.8k 2.1×	4.4k 3.0×	354 0.4×	249 0.3×	2.4k 3.5×	260	9.8k
Michael W. Long	508 0.3×	1.4k 0.9×	503 0.6×	564 0.7×	857 1.3×	121	9.7k

Countries citing papers authored by Catherine Gérard

Since Specialization

Citations

This map shows the geographic impact of Catherine Gérard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Gérard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Gérard more than expected).

Fields of papers citing papers by Catherine Gérard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Gérard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Gérard. The network helps show where Catherine Gérard may publish in the future.

Co-authorship network of co-authors of Catherine Gérard

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Gérard. A scholar is included among the top collaborators of Catherine Gérard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Gérard. Catherine Gérard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cunningham, Ruth, et al.. (2024). Primary care experience in people with mental health conditions: results from a national patient experience survey. New Zealand Medical Journal. 137(1606). 22–39.

Buynak, Robert, Kevin D. Cannon, John M. Kirby, et al.. (2024). Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65. Infectious Diseases and Therapy. 13(8). 1789–1805. 6 indexed citations

Gérard, Catherine, et al.. (2023). Finding an Appropriate Mouse Model to Study the Impact of a Treatment for Friedreich Ataxia on the Behavioral Phenotype. Genes. 14(8). 1654–1654. 4 indexed citations

Nokin, Marie‐Julie, Catherine Gérard, Agnès Noël, et al.. (2023). Role for the metalloproteinase ADAM28 in the control of airway inflammation, remodelling and responsiveness in asthma. Frontiers in Immunology. 13. 1067779–1067779. 3 indexed citations

Gérard, Catherine, et al.. (2023). Removal of the GAA repeat in the heart of a Friedreich’s ataxia mouse model using CjCas9. Gene Therapy. 30(7-8). 612–619. 3 indexed citations

Morton, Randall P., et al.. (2022). Persisting variance in middle ear ventilation tube insertion in Auckland children: why ethnic disparity continues. ResearchSpace (University of Auckland). 3 indexed citations

Rocks, Natacha, Catherine Gérard, Christine Gilles, et al.. (2019). ADAM10 mediates malignant pleural mesothelioma invasiveness. Oncogene. 38(18). 3521–3534. 17 indexed citations

Rioux, Clément R., Margie L. Clapper, Harry S. Cooper, et al.. (2019). Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models. PLoS ONE. 14(1). e0210261–e0210261. 7 indexed citations

Laubreton, Daphné, Sylvie Bay, Christine Sedlik, et al.. (2016). The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity. Cancer Immunology Immunotherapy. 65(3). 315–325. 22 indexed citations

10.

Gérard, Catherine, Silvia Blacher, Laudine Communal, et al.. (2014). Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation. Journal of Endocrinology. 224(1). 85–95. 58 indexed citations

11.

Barralet, Jake E., Uwe Gbureck, Pamela Habibović, et al.. (2009). Angiogenesis in Calcium Phosphate Scaffolds by Inorganic Copper Ion Release. Tissue Engineering Part A. 15(7). 1601–1609. 188 indexed citations

12.

Gérard, Catherine & C. Debruyne. (2009). Immunotherapy in the landscape of new targeted treatments for non‐small cell lung cancer. Molecular Oncology. 3(5-6). 409–424. 24 indexed citations

13.

Xia, Wenle, et al.. (2005). Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells. Oncogene. 24(41). 6213–6221. 211 indexed citations

14.

Grossin, Laurent, S. Étienne, Nadège Gaborit, et al.. (2004). Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo. Biorheology. 41(3-4). 521–534. 32 indexed citations

15.

Brichard, Vincent & Catherine Gérard. (2003). Melanoma vaccines: achievements and perspectives.. PubMed. 13(2). 144–54; quiz 189. 2 indexed citations

16.

Foy, Teresa M., Gary R. Fanger, Susan L. Hand, et al.. (2002). Designing HER2 vaccines. Seminars in Oncology. 29(3). 53–61. 29 indexed citations

17.

Gérard, Catherine, et al.. (2001). Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 7(3 Suppl). 838s–847s. 11 indexed citations

18.

Marchant, Arnaud, Catherine Bruyns, Peter Vandenabeele, et al.. (1994). Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia. European Journal of Immunology. 24(5). 1167–1171. 252 indexed citations

19.

Gérard, Catherine, Catherine Bruyns, Arnaud Marchant, et al.. (1993). Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.. The Journal of Experimental Medicine. 177(2). 547–550. 679 indexed citations breakdown →

20.

Goldman, Michel, Catherine Gérard, Daniel Abramowicz, et al.. (1992). Induction of interleukin‐6 and interleukin‐10 by the OKT3 monoclonal antibody: Possible relevance to posttransplant lymphoproliferative disorders. Clinical Transplantation. 6(3pt2). 265–268. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact